28 results
8-K
EX-99.1
ELTX
Elicio Therapeutics Inc.
23 May 24
Other Events
5:41pm
presentation at the American Society of Clinical Oncology (“ASCO”) Annual Meeting, being held May 31-June 4, 2024, in Chicago, IL. The preliminary
8-K
ELTX
Elicio Therapeutics Inc.
23 May 24
Other Events
5:41pm
-driven solid tumors at the 2024 American Society of Clinical Oncology Annual Meeting being held May 31-June 4, 2024 in Chicago, Illinois. A copy
8-K
EX-99.1
ELTX
Elicio Therapeutics Inc.
9 Jan 24
Nature Medicine Publishes Updated Preliminary Phase 1 Data From Elicio Therapeutic’s AMPLIFY-201 Phase 1 Solid Tumor Study of ELI-002
8:11am
at the 2023 American Society of Clinical Oncology (“ASCO”) Annual Meeting and the 2023 AACR Special Conference on Pancreatic Cancer.
“When tumor DNA
8-K
EX-99.1
l4n8ojvdv9y0newn6m
9 Nov 23
Results of Operations and Financial Condition
4:41pm
8-K
EX-99.1
nmh2lls7ba 1gu
3 Nov 23
Other Events
5:10pm
8-K
EX-99.1
5qcpwk7lc3fb
11 Aug 23
Elicio Therapeutics Reports Second Quarter 2023 Financial Results and Provides
11:42am
8-K
EX-99.1
523wy9 vgyxw25
5 Jun 23
Other Events
8:00am
8-K
obvpnrfp
5 Jun 23
Other Events
8:00am
8-K
EX-99.2
cqtbew
2 Jun 23
Angion Biomedia Corp. Announces 1-for-10 Reverse Stock Split
4:36pm
8-K
zy67d guox5
2 Jun 23
Angion Biomedia Corp. Announces 1-for-10 Reverse Stock Split
4:36pm
8-K
EX-99.3
14aowb ka050uu8qy
2 Jun 23
Angion Biomedia Corp. Announces 1-for-10 Reverse Stock Split
4:36pm
8-K
d209jq5vp1je4eid
1 May 23
Other Events
4:14pm
8-K
EX-99.1
wlsx5m391ezp5
1 May 23
Other Events
4:14pm
8-K
EX-99.1
oq211lpqbr5 ib10
27 Apr 23
Other Events
5:20pm
DEF 14A
oebap83rj3pbsfo6
27 Apr 22
Definitive proxy
4:04pm